Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 26.69% is 13% below its 5-year average of 30.51%, near the low end of its 5-year range (23.11%–38.10%).
As of the fiscal period ended Tuesday, June 30, 2026. 9.18% below its 12-month average of 29.39%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 26.69%.
DEBT TO ASSETS RATIO
26.69%
DEBT TO ASSETS RATIO AVG TTM
29.39%
DEBT TO ASSETS RATIO AVG 3Y
33.31%
DEBT TO ASSETS RATIO AVG 5Y
30.51%
DEBT TO ASSETS RATIO AVG 10Y
26.61%
DEBT TO ASSETS RATIO AVG 15Y
21.83%
DEBT TO ASSETS RATIO AVG 20Y
16.83%
CURRENT VS TTM AVG
-9.18%
CURRENT VS 3Y AVG
-19.86%
CURRENT VS 5Y AVG
-12.51%
CURRENT VS 10Y AVG
+0.31%
CURRENT VS 15Y AVG
+22.30%
CURRENT VS 20Y AVG
+58.57%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 595 covered companies
CURRENT VS SECTOR MEDIAN
+26594.38%
vs the sector median at left
ImmuCell Corporation
Market Cap
$90.20M
Debt to Assets Ratio
26.69%
TTM Avg
29.39%
3Y Avg
33.31%
5Y Avg
30.51%
Market Cap
$90.37M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$86.25M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$94.94M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$85.15M
Debt to Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ImmuCell Corporation (ICCC) | $90.20M | 26.69% | 29.39% | 33.31% | 30.51% |
| Biomea Fusion, Inc. (BMEA)vs › | $90.37M | 0.02% | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $88.52M | 0.01% | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $92.14M | 0.56% | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 0.58% | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $86.25M | 0.01% | N/A | N/A | N/A |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $94.94M | 0.00% | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $95.15M | 0.26% | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $85.15M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | 0.01% | N/A | N/A | N/A |
Debt/Assets
26.7%
Debt/Equity
0.40
Current Ratio
4.75
Interest Coverage
3.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 26.69% |
| 2026-03-31 | 28.97% |
| 2025-12-31 | 31.02% |
| 2025-09-30 | 29.75% |
| 2025-06-30 | 30.53% |
| 2025-03-31 | 32.13% |
| 2024-12-31 | 33.48% |
| 2024-09-30 | 34.95% |
| 2024-06-30 | 37.84% |
| 2024-03-31 | 37.80% |
| 2023-12-31 | 38.10% |
| 2023-09-30 | 37.45% |
| 2023-06-30 | 34.31% |
| 2023-03-31 | 30.66% |
| 2022-12-31 | 27.82% |
| 2022-09-30 | 27.42% |
| 2022-06-30 | 25.62% |
| 2022-03-31 | 25.77% |
| 2021-12-31 | 23.11% |
| 2021-09-30 | 23.72% |
| 2021-06-30 | 23.57% |
| 2021-03-31 | 26.56% |
| 2020-12-31 | 26.60% |
| 2020-09-30 | 27.44% |
| 2020-06-30 | 27.40% |
| 2020-03-31 | 24.64% |
| 2019-12-31 | 21.77% |
| 2019-09-30 | 22.23% |
| 2019-06-30 | 22.45% |
| 2019-03-31 | 22.37% |
| 2018-12-31 | 29.84% |
| 2018-09-30 | 28.52% |
| 2018-06-30 | 27.85% |
| 2018-03-31 | 27.32% |
| 2017-12-31 | 26.11% |
| 2017-09-30 | 19.39% |
| 2017-06-30 | 15.05% |
| 2017-03-31 | 12.89% |
| 2016-12-31 | 12.20% |
| 2016-09-30 | 14.80% |
| 2016-06-30 | 14.95% |
| 2016-03-31 | 15.29% |
| 2015-12-31 | 22.10% |
| 2015-09-30 | 22.92% |
| 2015-06-30 | 7.10% |
| 2015-03-31 | 7.54% |
| 2014-12-31 | 8.11% |
| 2014-09-30 | 8.80% |
| 2014-06-30 | 9.22% |
| 2014-03-31 | 9.35% |
| 2013-12-31 | 9.91% |
| 2013-09-30 | 10.24% |
| 2013-06-30 | 10.36% |
| 2013-03-31 | 11.01% |
| 2012-12-31 | 11.50% |
| 2012-09-30 | 11.96% |
| 2012-06-30 | 12.28% |
| 2012-03-31 | 12.52% |
| 2011-12-31 | 13.11% |
| 2011-09-30 | 13.51% |
| 2011-06-30 | 13.50% |
| 2011-03-31 | 13.72% |
| 2010-12-31 | 9.17% |
| 2010-09-30 | 9.29% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 7.04% |
| 2005-09-30 | 6.32% |
| 2005-06-30 | 7.56% |
| 2005-03-31 | 8.76% |
| 2004-12-31 | 10.35% |
| 2004-09-30 | 4.89% |
| 2004-06-30 | 4.92% |
| 2004-03-31 | 4.85% |
| 2003-12-31 | 4.89% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 4.93% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 3.99% |
| 2002-09-30 | 0.00% |
